What is the appropriate dose of Luvox (fluvoxamine)?

Appropriate Dosing of Luvox (Fluvoxamine)

For adults, start fluvoxamine at 50 mg once daily at bedtime, then increase by 50 mg increments every 4-7 days as tolerated to a target range of 100-300 mg/day, with doses above 100 mg given in divided doses (larger dose at bedtime). 1

Adult Dosing

• Initial dose: 50 mg once daily at bedtime 1
• Titration schedule: Increase in 50 mg increments every 4-7 days as tolerated 1
• Therapeutic range: 100-300 mg/day 2, 1
• Maximum dose: 300 mg/day 1
• Dosing frequency: Total daily doses >100 mg should be split into two divided doses, with the larger dose given at bedtime 1

The FDA-approved dosing is supported by clinical trial data showing efficacy at 100-300 mg/day for OCD 1. Research evidence demonstrates that higher doses (100-150 mg/day) are more effective than lower doses (50-75 mg/day) for depression, with 73.7% improvement at higher doses versus 47.1% at lower doses 3. However, one study found 50-150 mg/day effective for major depression 4.

Pediatric Dosing (Ages 8-17)

• Initial dose: 25 mg once daily at bedtime 1
• Titration schedule: Increase in 25 mg increments every 4-7 days as tolerated 1
• Therapeutic range: 50-200 mg/day 1
• Maximum dose in children ≤11 years: 200 mg/day 1
• Maximum dose in adolescents: 300 mg/day 1
• Dosing frequency: Total daily doses >50 mg should be split into two divided doses, with the larger dose at bedtime 1

Female children may achieve therapeutic effect at lower doses 1.

Special Populations

Elderly and hepatically impaired patients require dose modification due to decreased clearance of fluvoxamine 1. Start with lower initial doses and titrate more slowly in these populations 1.

For pregnant women in the third trimester, carefully weigh risks versus benefits and consider tapering fluvoxamine due to neonatal complications including respiratory distress and persistent pulmonary hypertension 1.

Dosing Considerations by Indication

Depression

• Effective range: 100-150 mg/day shows superior efficacy 3
• Alternative range: 50-150 mg/day demonstrated effectiveness comparable to imipramine in one trial 4
• Time to response: Most patients respond within 6 weeks; consider changing treatment if no improvement by 6 weeks 3

Anxiety Disorders (Children and Adolescents)

• Titration approach: Use 1-2 week intervals for dose increases given fluvoxamine's shorter half-life 2
• Starting strategy: Consider subtherapeutic "test" dose initially, as SSRIs can cause initial anxiety or agitation 2

Alzheimer's Disease-Related Depression

• Initial dose: 50 mg twice daily 2
• Maximum dose: 150 mg twice daily 2
• Caution: Exercise care when combining with alprazolam or triazolam due to drug interactions 2

Critical Safety Considerations

Fluvoxamine has extensive drug-drug interactions through inhibition of CYP1A2, CYP2C19, CYP2C9, CYP3A4, and CYP2D6 2. This gives fluvoxamine greater potential for interactions compared to other SSRIs 2.

Contraindications:

• Concurrent MAOI use (allow 14 days washout period in either direction) 2, 1
• Avoid combining with other serotonergic drugs due to serotonin syndrome risk 2

Discontinuation syndrome risk: Fluvoxamine is associated with withdrawal symptoms including dizziness, fatigue, nausea, and sensory disturbances 2. Always taper gradually rather than stopping abruptly 1.

Monitoring Requirements

• Suicidality monitoring: Close monitoring required, especially in first months and after dose changes, per FDA black box warning 2
• Adverse effects: Monitor for nausea, somnolence, behavioral activation, and gastrointestinal symptoms 2
• Response assessment: Therapeutic effect typically emerges by week 6, with maximal improvement by week 12 2

Practical Dosing Algorithm

1. Start 50 mg at bedtime (25 mg in children 8-17 years) 1
2. Assess tolerance after 4-7 days 1
3. If tolerated, increase by 50 mg (25 mg in children) 1
4. Continue titration every 4-7 days until therapeutic benefit achieved or maximum dose reached 1
5. Split doses when total exceeds 100 mg/day (50 mg/day in children), giving larger dose at bedtime 1
6. Target 100-150 mg/day for depression based on efficacy data 3
7. Reassess at 6 weeks; if no response, consider alternative treatment 3